{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T12:50:21Z","timestamp":1777639821962,"version":"3.51.4"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/s13075-024-03434-2","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T01:34:08Z","timestamp":1731375248000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical practice pattern of Pneumocystis pneumonia prophylaxis in systemic lupus erythematosus: a cross-sectional study from lupus registry of nationwide institutions (LUNA)"],"prefix":"10.1186","volume":"26","author":[{"given":"Takahisa","family":"Onishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1020-0818","authenticated-orcid":false,"given":"Ken-ei","family":"Sada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keigo","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshia","family":"Miyawaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryusuke","family":"Yoshimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Shimojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kajiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiro","family":"Ichinose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuzo","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michio","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Yajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Yamane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,12]]},"reference":[{"key":"3434_CR1","doi-asserted-by":"publisher","first-page":"e0214324","DOI":"10.1371\/journal.pone.0214324","volume":"14","author":"T Kageyama","year":"2019","unstructured":"Kageyama T, Furuta S, Ikeda K, Kagami S-I, Kashiwakuma D, Sugiyama T, et al. Prognostic factors of Pneumocystis pneumonia in patients with systemic autoimmune diseases. PLoS ONE. 2019;14:e0214324.","journal-title":"PLoS ONE"},{"key":"3434_CR2","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jmii.2012.08.024","volume":"47","author":"M-C Li","year":"2014","unstructured":"Li M-C, Lee N-Y, Lee C-C, Lee H-C, Chang C-M, Ko W-C. Pneumocystis jiroveci pneumonia in immunocompromised patients: delayed diagnosis and poor outcomes in non-HIV-infected individuals. J Microbiol Immunol Infect. 2014;47:42\u20137.","journal-title":"J Microbiol Immunol Infect"},{"key":"3434_CR3","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.idc.2023.03.005","volume":"37","author":"PA Trubin","year":"2023","unstructured":"Trubin PA, Azar MM. Current concepts in the diagnosis and management of pneumocystis pneumonia in solid organ transplantation. Infect Dis Clin North Am. 2023;37:617\u201340.","journal-title":"Infect Dis Clin North Am"},{"key":"3434_CR4","first-page":"CD005590","volume":"2014","author":"A Stern","year":"2014","unstructured":"Stern A, Green H, Paul M, Vidal L, Leibovici L. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. Cochrane Database Syst Rev. 2014;2014:CD005590.","journal-title":"Cochrane Database Syst Rev."},{"key":"3434_CR5","doi-asserted-by":"publisher","first-page":"152257","DOI":"10.1016\/j.semarthrit.2023.152257","volume":"63","author":"A Xiong","year":"2023","unstructured":"Xiong A, Luo W, Tang X, Cao Y, Xiang Q, Deng R, et al. Risk factors for invasive fungal infections in patients with connective tissue disease: Systematic review and meta-analysis. Semin Arthritis Rheum. 2023;63:152257.","journal-title":"Semin Arthritis Rheum"},{"key":"3434_CR6","doi-asserted-by":"publisher","first-page":"e037419","DOI":"10.1136\/bmjopen-2020-037419","volume":"10","author":"L Li","year":"2020","unstructured":"Li L, Hsu SH, Gu X, Jiang S, Shang L, Sun G, et al. Aetiology and prognostic risk factors of mortality in patients with pneumonia receiving glucocorticoids alone or glucocorticoids and other immunosuppressants: a retrospective cohort study. BMJ Open. 2020;10:e037419.","journal-title":"BMJ Open"},{"key":"3434_CR7","doi-asserted-by":"publisher","unstructured":"Fanouriakis A, Kostopoulou M, Andersen J, Aringer M, Arnaud L, Bae S-C, et al. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis. 2023. https:\/\/doi.org\/10.1136\/ard-2023-224762","DOI":"10.1136\/ard-2023-224762"},{"key":"3434_CR8","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s00296-008-0721-6","volume":"29","author":"R Lertnawapan","year":"2009","unstructured":"Lertnawapan R, Totemchokchyakarn K, Nantiruj K, Janwityanujit S. Risk factors of Pneumocystis jeroveci pneumonia in patients with systemic lupus erythematosus. Rheumatol Int. 2009;29:491\u20136.","journal-title":"Rheumatol Int"},{"key":"3434_CR9","first-page":"265","volume":"19","author":"M Petri","year":"1992","unstructured":"Petri M, Allbritton J. Antibiotic allergy in systemic lupus erythematosus: a case-control study. J Rheumatol. 1992;19:265\u20139.","journal-title":"J Rheumatol"},{"key":"3434_CR10","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.","journal-title":"Arthritis Rheum"},{"key":"3434_CR11","first-page":"288","volume":"29","author":"DD Gladman","year":"2002","unstructured":"Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29:288\u201391.","journal-title":"J Rheumatol"},{"key":"3434_CR12","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/art.1780390303","volume":"39","author":"D Gladman","year":"1996","unstructured":"Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics\/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum. 1996;39:363\u20139.","journal-title":"Arthritis Rheum"},{"key":"3434_CR13","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1136\/ard-2022-223335","volume":"82","author":"GE Fragoulis","year":"2023","unstructured":"Fragoulis GE, Nikiphorou E, Dey M, Zhao SS, Courvoisier DS, Arnaud L, et al. 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. 2023;82:742\u201353.","journal-title":"Ann Rheum Dis"},{"key":"3434_CR14","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1136\/annrheumdis-2017-211796","volume":"77","author":"JW Park","year":"2018","unstructured":"Park JW, Curtis JR, Moon J, Song YW, Kim S, Lee EB. Prophylactic effect of trimethoprim-sulfamethoxazole for pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids. Ann Rheum Dis. 2018;77:644\u20139.","journal-title":"Ann Rheum Dis"},{"key":"3434_CR15","doi-asserted-by":"publisher","first-page":"152106","DOI":"10.1016\/j.semarthrit.2022.152106","volume":"57","author":"B Boone","year":"2022","unstructured":"Boone B, Lazaroff SM, Wheless L, Wolfe RM, Barnado A. Rates of Pneumocystis jirovecii pneumonia and prophylaxis prescribing patterns in a large electronic health record cohort of patients with systemic lupus erythematosus. Semin Arthritis Rheum. 2022;57:152106.","journal-title":"Semin Arthritis Rheum"},{"key":"3434_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3109\/PL00021707","volume":"15","author":"J Ogawa","year":"2005","unstructured":"Ogawa J, Harigai M, Nagasaka K, Nakamura T, Miyasaka N. Prediction of and prophylaxis against Pneumocystis pneumonia in patients with connective tissue diseases undergoing medium- or high-dose corticosteroid therapy. Mod Rheumatol. 2005;15:91\u20136.","journal-title":"Mod Rheumatol"},{"key":"3434_CR17","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.reuma.2020.02.006","volume":"17","author":"P Vela Casasempere","year":"2021","unstructured":"Vela Casasempere P, Ruiz Torregrosa P, Garc\u00eda SR. Pneumocystis jirovecii in immunocompromised patients with rheumatic diseases. Reumatol Clin. 2021;17:290\u20136.","journal-title":"Reumatol Clin"},{"key":"3434_CR18","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12879-020-4826-1","volume":"20","author":"K-J Yeo","year":"2020","unstructured":"Yeo K-J, Chen H-H, Chen Y-M, Lin C-H, Chen D-Y, Lai C-M, et al. Hydroxychloroquine may reduce risk of Pneumocystis pneumonia in lupus patients: a Nationwide, population-based case-control study. BMC Infect Dis. 2020;20:112.","journal-title":"BMC Infect Dis"},{"key":"3434_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11926-017-0664-6","volume":"19","author":"RM Wolfe","year":"2017","unstructured":"Wolfe RM, Peacock JE Jr. Pneumocystis Pneumonia and the Rheumatologist: Which Patients Are At Risk and How Can PCP Be Prevented? Curr Rheumatol Rep. 2017;19:35.","journal-title":"Curr Rheumatol Rep"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-024-03434-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-024-03434-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-024-03434-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T14:03:18Z","timestamp":1731420198000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-024-03434-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,12]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3434"],"URL":"https:\/\/doi.org\/10.1186\/s13075-024-03434-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4904868\/v1","asserted-by":"object"}]},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,12]]},"assertion":[{"value":"13 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and Ethical Guidelines for Epidemiologic Research in Japan. The study protocol was approved by the Ethics Committee of Kakogawa Central City Hospital (authorization number: 2021\u201304). The patients provided written informed consent to participate in the and permission to publish their data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and informed consent"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"KS received speaker fees from Glaxo Smith Kline and a research grant from Pfizer Inc. TY received speaker fees from Glaxo Smith Kline.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"198"}}